Stay updated on Pembrolizumab in NSCLC with PS 2 Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in NSCLC with PS 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in NSCLC with PS 2 Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-17T23:41:39.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1, while the study page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-10T23:38:37.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a simplified HTML structure and basic header/footer, replacing the previous study content and navigation with an access-restricted notice.
    Difference
    18%
    Check dated 2026-09-19T22:24:54.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    An NIH grant/contract note for 2015 was added and the revision label updated from v3.6.5 to v3.6.6, reflecting metadata/versioning updates rather than study content.
    Difference
    0.1%
    Check dated 2026-08-29T19:07:59.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    - The page revision label updated from v3.6.4 to v3.6.5, representing a minor version update to the page metadata.
    Difference
    0.0%
    Check dated 2026-08-08T09:43:49.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page’s revision label was updated from Revision: v3.6.3 to Revision: v3.6.4, indicating a new version of the page template.
    Difference
    0.0%
    Check dated 2026-07-25T07:37:52.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in NSCLC with PS 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NSCLC with PS 2 Clinical Trial page.